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The Rhipicephalus microplus tick is responsible for losses in the livestock production estimated in 2
billions USD. Despite its economical importance the knowledge in tick's physiology is sparse. In order to
contribute to this scenario we describe the characterization of a cysteine proteinase inhibitor named
Rmcystatin-3. Puriﬁed recombinant Rmcystatin-3 was able to inhibit cathepsin L (Ki ¼ 2.5 nM), BmCl1
(Ki ¼ 1.8 nM) and cathepsin B (Ki ¼ 136 nM). Western blot and quantitative PCR analysis revealed the
presence of Rmcystatin-3 in fat body, salivary gland but mainly in hemocytes. The mRNA levels of
Rmcystatin-3 during bacterial challenge are drastically down-regulated. In order to deﬁne the
Rmcystatin-3 possible role in tick immunity, the cystatin gene was knockdown by RNA interference with
and without Escherichia coli infection. Our results showed that the Rmcystatin-3 silenced group was
more immune competent to control bacterial infection than the group injected with non-related dsRNA.
Taking together, our data strongly suggested an important role of Rmcystatin-3 in tick immunity.
© 2014 Elsevier B.V. and Societe française de biochimie et biologie Moleculaire (SFBBM). All rights
reserved.1. Introduction [15]. The Drosophila immune model [16] appears to be a solid baseThe cattle tick Rhipicephalus microplus is responsible for major
losses in livestock production in tropical and subtropical regions.
Tick parasitism can cause severe anemia, reduction of milk and
meat production, diminish the value of skin, and leather production
[1,2]. R. microplus can also act as vector of bovine pathogens known
as the tick-babesia spp.-anaplasma spp complex which is the most
important tickepathogen relation in the world [3]. Tick control is
based on acaricides, which lead to the selection of resistant strains
and environmental contamination, making necessary the devel-
opment of alternative control methods [4e6].
Despite the recent advances in invertebrate immunology, the
knowledge in tick immunity is still sparse. Tick cellular response is
mediated by hemocytes e circulating cells in hemolymph e to
which the phagocytic activity is attributed [7e9]. In addition,
complement-related molecules such as a-2-macroglobulins were
described in several tick species associated with phagocytosis
[10e12]. Tick humoral response consist of a vast repertory of
antimicrobial peptides (AMPs) such as ixodidin [13], microplusin
[14] and the ability to produce AMPs through hemoglobin digestion5 11 55761080.
.
de biochimie et biologie Moleculafor invertebrate immunity and intermediates from both TOLL and
IMD pathways are conserved in other arthropods such asmosquitos
[17], crustacean [18] and can also be found in Ixodes scapularis
genome, suggesting the presence of such pathway in ticks. How-
ever, none conclusive data have been shown. Protease inhibitors
also participate in tick immunity [19,20] among them, a type-2
cystatin from Haemaphysalis longicornis was able to inhibit the
in vitro growth of Babesia gibsoni [21].
The cystatin superfamily is traditionally characterized by tight-
binding inhibitors of cysteine proteinases, which are largely distrib-
uted among live beings [22]. The cystatin family is comprised of three
subfamilies classiﬁed based on their primary sequence: (i) Steﬁns are
11 kDa inhibitors with absence of signal peptide and disulphide
bridges, (ii) cystatins present molecular weight from 13 to 15 kDa,
with a signal peptide and two disulphide bridges, and (iii) kininogens
are multi domain proteins with eight disulphide bridges and high
molecular weight [23,24]. Although, there is a new classiﬁcation of
the Cystatin family available on MEROPS based on the number of
cystatin domains present in the inhibitors [25]. In the last few years,
several tick cystatinshavebeencharacterizedandassociatedwith the
parasiteehost interface modulating host immunity [26e28], blood
feeding [29] and pathogen transmission [30]. A few cystatins have
been related to hemoglobin digestion [31] and embryogenesis [32].ire (SFBBM). All rights reserved.
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(R. microplus cystatin 3), located in hemocytes of R. microplus and
related to the tick immune response.
2. Materials and methods
2.1. Animals
R. microplus ticks (Babesia spp.-free) was supplied by Dr. Itaba-
jara da Silva Vaz Junior of Centro de Biotecnologia, Universidade
Federal do Rio Grande do Sul, RS, Brazil.
2.2. Rmcystatin-3 oligonucleotide design
Rmcystatin-3 primers were designed based on the predicted
sequence obtained from a cDNA library of hemocytes by adding the
restrictions sites of Sac II and Xba I enzymes at the 50 and 30
respectively. The sense oligonucleotides was: Rmcys3_FW 50-
CCGCGGGCCAATCCTGTAGGG-30 and the antisense oligonucleotide:
Rmcys3_RV 50-TCTAGATTAATTTGAAGTGGC-30.
2.3. Ampliﬁcation and cloning of Rmcystatin-3 DNA fragment
A Rmcystatin-3 DNA fragment was ampliﬁed from a cDNA li-
brary of hemocytes by PCR. The reactions were performed in a 50 mL
ﬁnal volume using 1.5 mM MgCl2, 100 mM dNTPs, 10 pmol of each
primer, 5 U Taq DNA polymerase (Fermentas), and its correspond-
ing buffer [100 mM TriseHCl pH 8.8, 500 mM KCl, and 0.8% (v/v)].
The PCR parameters were: pre-denaturation at 94 C for 10 min; 35
cycles of (94 C for 45 s, 55 C for 45 s, 72 C for 1 min); followed by
5min at 72 C. Rmcystatin-3 fragment was separated by agarose gel
electrophoresis 1% (w/v) and puriﬁed using QIAEX II gel extraction
system according the manufacturer's instructions (QIAGEN).
Rmcystatin-3 puriﬁed fragment and the expression vector pPICZaB
were submitted to a double digestion, with Sac II and Xba I en-
zymes, in Tango buffer, overnight at 37 C, followed by the ligation
of the digested fragment to the vector. Escherichia coli DH5a strain
were transformed using the construction pPICzaB-Rmcystatin-3
and plated on Lenox Broth (LB) agar plates (1% tryptone, 0.5% yeast
extract, 0.5 NaCl) containing 25 mg/mL of Zeocin. Positive clones for
DNA insertion were veriﬁed by DNA sequencing and one corrected
construction was used in a midi-plasmid DNA preparation using
Plasmid Midi Kit from QIAGEN (Hilden, Germany).
2.4. Preparation and transformation of Pichia pastoris yeast
P. pastoris GS115 strain was grown in a yeast extract-peptone-
dextrose (YPD) medium and prepared for transformation by elec-
troporation following the manufacturer's instructions. After line-
arization of plasmid Rmcystatin3-pPICZaB (10 mg) with Sac I
restriction enzyme, competent P. pastoris GS115 were transformed
by electroporation. Yeast transformation was performed in a 0.2 cm
cuvette in a Gene Pulser (Bio-Rad, Hercules, CA) using the following
parameters: 1.5 kV, 25 mF and 400 U. The electroporated cells were
immediately suspended in 1.0 mL of ice-cold 1.0 M sorbitol and
spread onMD agar plate (1.34% YNB, 2% dextrose, 4 105% biotin),
without histidine. The target gene in the recombinants was detec-
ted by PCR reactions using 30AOX and 50AOX primers from Invi-
trogen (Carlsbad, CA, USA) and some positive clones were selected.
2.5. Expression of Rmcystatin-3
One isolated colony of P. pastoris GS115 Mutþ strain containing
Rmcystatin3-pPICZaB construction was inoculated in 160 mL of
BMGY medium [1.0% yeast extract, 2.0% peptone in 100 mMpotassium phosphate buffer pH 6.0, 1.34% YNB, 4  105 (w/v) D-
biotin and 1% (v/v) glycerol] in 1 L sterile ﬂask, and cultivated at
30 C, 190 rpm until to reach 6.0 in A600. Yeast cells were separated
by centrifugation at 3000 g for 15 min at 4 C and resuspended in
BMMY medium [1.0% yeast extract, 2.0% peptone in 100 mM po-
tassium phosphate buffer at pH 6.0, 1.34% YNB 4  105% (w/v) D-
biotin and 0.5% (v/v) methanol] at 1.0 in A600. Expression of re-
combinant protein was induced by the addition of methanol (0.5%
ﬁnal concentration) every 24 h for the next 96 h at 30 C and
shaking at 190 rpm. By the end of the fourth day, the yeast cells
were removed by centrifugation (3000 g for 15 min at 4 C) and the
supernatant stored at 4 C for protein puriﬁcation.
2.6. Puriﬁcation of recombinant Rmcystatin-3
Recombinant Rmcystatin-3 was puriﬁed fromyeast supernatant
by an ionic exchange chromatography using a HiPrep Q column
connected to a AKTA prime plus (GE Healthcare Life Sciences)
previously equilibrated with 25 mM TriseHCl buffer pH 8.0 and
eluted with a crescent gradient of 25 mM TriseHCl buffer pH 8.0
containing 1 M NaCl. Afterward, Rmcystatin-3 was further puriﬁed
on a size exclusion chromatography using a Superdex75 column
previously equilibrated with 25 mM TriseHCl buffer pH 8.0 con-
taining 0.2MNaCl. Collected fractions containing inhibitory activity
against cathepsin L were analyzed by SDS-PAGE.
2.7. SDS-polyacrylamide electrophoresis (SDS-PAGE)
SDS-PAGE was performed according to Laemmli [33]. SDS-PAGE
(15%) with 5% stacking gel was used to analyze puriﬁed Rmcystatin-
3. Proteins were stained by Coomassie Brilliant Blue R-250 solution.
2.8. Rmcystatin-3 gene silencing by RNA interference
Rmcystatin-3 gene silencing was performed by producing
double stranded RNA (dsRmcys3) using the T7 Ribomax Express
RNAi system (Promega) and the Rmcystatin-3 DNA fragment was
ampliﬁed by PCR using primers conjugated with T7 promoter site:
dsRmcys3_FW:
50-GGATCCTAATACGACTCACTATAGGGCCAATCCTGTAGGGCTCG
TG-30 and dsRmcys3_RV 50-GGATCCTAATACGACTCACTATAGGGC
CAATCCTGTAGGGCTCGTG-30, and applied in 1% (w/v) agarose gel
and puriﬁed with QIAEX II kit (QIAGEN). The dsRmcys3 was
digested with DNAse (1 mg/mL) and RNAse (1 mg/mL), precipitated
with ethanol and resuspended in sterile PBS. The dsRNA quantiﬁ-
cation was made by absorbance at 260 nm and the quality of the
material valued by the 260/280 ratio. It was using preparations
with 260/280 above 1.7. Engorged female ticks were divided in
groups injected with: dsRmcys3, dsLAC (non-related control),
bacterial suspension (1  104 CFU/mL) and bacterial suspension
plus dsRmcys3, respectively. All groups 24 h post-injection were
used to collect hemolymph. Afterward, 2 mL of hemolymph were
diluted in 198 mL LBmedium and plated in LB agar plates containing
20 mg/mL of kanamycin. The hemocytes were separated from he-
molymph by centrifugation at 800 g for 10 min and to them were
added Trizol and stored at 20 C. The hemolymph was stored
at 20 C.
2.9. Quantitative real-time PCR
Different tissues e midgut, ovary, hemocytes, fat body and
salivary gland e were dissected. All tissues were used for RNA and
protein extractions from Trizol solution. RNA preparations were
used for cDNA synthesis using the ImProm-II Reverse Transcription
System (Promega). The presence of Rmcystatin-3mRNA in different
Fig. 1. Analysis of nucleotide and translated amino acid sequence of Rmcystatin-3. (A): The predicated signal peptide (SignalP) is underlined. Cysteine residues are in gray and the
conserved motifs of a cystatin are boxed. (B): Alignment of amino acid sequence of Rmcystatin-3 and cystatins among tick species, identical residues are black boxed while similar
residues are gray boxed. Rmicroplus-2b (Rhipicephalus microplus) GenBank: AGW80658.1; Hlongircornis (Haemaphysalis longicornis) GenBank: ABV71390.1; Rappendiculatus
(Rhipicephalus appendiculatus) GenBank: AGB35873.1.
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TTA CGC CGT CTC ACA ACA AG-30 and Rmcy3_RV: 50-ACA TCC TTC
ACC GTC TCT CG-30. The elongation factor-1alpha (ELF1a) was used
as endogenous control [34], using the primers: ELF1a_FW 50-CGTCTACAAGATTGGTGGCATT-30 and ELF1a_RV 50-CTCAGTGGT-
CAGGTTGGCAG-30. The Rmcystatin-3 and ELF1a gene were quan-
tiﬁed using SYBR-Green PCR Master Mix in a 7500 Fast Real Time
PCR System (Applied Biosystems), according to the following
Fig. 2. Puriﬁcation of rRmcystatin-3: (A): The supernatant of Pichia pastoris GS115
strain culture containing Rmcystatin-3 was submitted to an ionic exchange chroma-
tography on a Hiprep Q column, proteins were eluted with a linear gradient of NaCl
(0e1 M), the dash indicates the region containing inhibitory activity for cathepsin L.
(B): Size exclusion chromatography in a Superdex75 column. The dash indicated the
fractions containing inhibitory activity for cathepsin L. (C): Rmcystatin-3 analysis by
SDS-PAGE (15%) sample pre-incubated with reducing agent (1) and (2) the marker
PageRuler.
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for 1 min. For each tissue, 10 ng of cDNA were used as template in
two independent experiments. The amount of each mRNA was
calculated according to the 2-DDCt method.
2.10. Western-blot analysis
Ticks tissues were used for protein extraction preparation using
Trizol manufacturer's instructions. 50 mg of total protein from each
tissue were separated on a 12% SDS-PAGE and transfer to a PVDF
membrane by electrophoretic transfer system Mini Trans-Blot Cell
(BioRad, Hercules, CA) for 45 min using 15 V. PVDF membrane was
incubated for 1 h with PBS containing Tween 0.1% and 5% of
skimmed milk at room temperature. After blocking, the PVDF
membrane was washed three times with PBS containing Tween
0.1% for 15 min, following by incubation with puriﬁed anti-serum
diluted 1:100 in blocking buffer, overnight at 4 C. PVDF mem-
brane was washed and incubated with anti-rabbit IgG conjugated
with peroxidase (dilution 1:20,000) for 1 h at room temperature.
The membrane was stained with SuperSignal West Pico Chem-
ilumiescent Substrate (Pierce) and exposed for 2 min. The image
was capture with the image-capturer MR-ChemBIS 3.2 (DNR Bio-
imaging System).
2.11. Determination of dissociation constant (Ki)
Cysteine proteinases, cathepsin L, BmCl1 and papain were pre-
incubated in 50 mM sodium acetate buffer pH 5.5 containing
1 mM DTT at 37 C for 10 min. Activated enzymes were pre-
incubated with different concentrations of puriﬁed recombinant
Rmcystatin-3 followed the addition of Z-Phe-Arg-MCA substrate
(2 mM) for papain, cathepsin L and BmCl1, and the substrate Z-Arg-
Arg-MCA (2 mM) for cathepsin B. The residual activity was
measured at 380 nm excitation and 460 nm emissions. The disso-
ciation constant calculated by ﬁtting steady-state velocities to
Morrison equation (Vi/Vo ¼ 1  {Et þ It þ Ki 
[(Et þ It þ Ki)2  4EtIt]1/2}/2Et) for tight-binding inhibitors [35].
3. Results
3.1. Rmcystatin-3 nucleotide and amino acid sequences analysis
The nucleotide sequence of Rmcystatin-3 (R. microplus cystatin-
3) was identiﬁed in a hemocyte cDNA library of bovine tick. The
sequence showed a 426-bp-ORF and an amino acid sequence
characteristic of the family 2 cystatins: a signal peptide with
cleavage site between amino acid residues 24 and 25 and four
cysteine residues. Rmcystatin-3 primary structure reveals a mature
protein of 142 aa (Fig. 1A) with a theoretical molecular weight of
13 kDa and isoelectric point (pI) of 5.39. The multiple sequence
alignment with other tick cystatins reveals the conserve motifs
among cystatin family, the Gly residue on N-terminal, the motif
QxVxG and the pair prolineetryptophan at the C-terminal (Fig. 1B).
3.2. Cloning, expression and puriﬁcation of rRmcystatin-3
The DNA fragment encoding for Rmcystatin-3 was cloned in the
pPICZaB vector and expressed using the yeast expression system
with P. pastorisGS115Mutþ strain. The protein expression yield was
35 mg/L. The recombinant protein (rRmcystatin-3) was puriﬁed by
an ionic exchange chromatography using a HiPrep Q column
(Fig. 2A). Fractions were screened for inhibitory activity against
cathepsin L and submitted to a size exclusion chromatography in a
Superdex75 column (Fig. 2B), and them analyzed by SDS-PAGE
revealing a major protein around 15 kDa (Fig. 2C).3.3. Characterization of rRmcystatin-3 inhibitory activity
To determine rRmcystatin-3 inhibitory speciﬁcity, puriﬁed in-
hibitor was assayed with different cysteine proteases: papain,
cathepsin L, Boophilus microplus cathepsin L-1 (BmCl-1) and
cathepsin B (Fig. 3). Table 1 summarized dissociation constant data
for different cysteine proteases; rRmcystatin-3 strongly inhibited
human cathepsin L (Ki¼ 2.45 nM), BmCl1 (Ki¼ 1.8 nM), cathepsin B
(Ki ¼ 136 nM) but not papain.
Fig. 3. Dissociation curves of rRmcystatin-3 for cathepsin B and BmCl-1. The values of
the dissociation constant (Ki) were calculated by ﬁtting steady-state velocities to
Morrison equation (Vi/Vo ¼ 1  {Et þ It þ Ki  [(Et þ It þ Ki)2  4EtIt]1/2}/2Et) for tight-
binding inhibitors.
Fig. 4. Localization of Rmcystatin-3 in R. microplus tick. (A): Rmcystatin-3 gene
expression proﬁle in different tissues of engorged females by quantitative PCR. All data
were normalized by expression level of ELF1a (elongation factor 1-alpha) as endoge-
nous control. The error bars correspond to the standard error of the mean from two
independent experiments. (B): Protein extract from tick tissues (1) midgut, (2) ovary,
(3) hemocytes, (4) fat body, (5) salivary gland, (6) hemolymph and the (7) recombinant
Rmcystatin-3 were used in Western-blotting assays with an anti-Rmcystatin-3 puriﬁed
polyclonal antibody.
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Rmcystatin-3 expression proﬁle was analyzed by quantitative
real time PCR using cDNA preparation from different tissues e
midgut, ovary, hemocytes, fat body and salivary gland e of
R. microplus. Rmcystatin-3 mRNA was detected in hemocytes, fat
body and salivary glands (Fig. 4A). Despite the localization of
Rmcystatin-3 mRNA among tick tissues, Western blot analysis us-
ing a puriﬁed polyclonal antibodies anti-Rmcystatin-3 revealed the
presence of the native inhibitor only in hemocytes and fat body
(Fig. 4B).
3.5. Rmcystatin-3 knockdown by RNA interference
The proﬁle of Rmcystatin-3 mRNA during RNA interference was
analyzed by quantitative real time PCR and western blot. The tick
group injected only with PBS showed a decreased in the
Rmcystatin-3 expression. As expected the injection of
dsRmcystatin-3 (3.5 mg/mL) successfully knocked down the
Rmcystatin-3 expression while the injection of the double-strand
non-related gene (dsNR e 3.5 mg/mL) revealed a similar effect of
the PBS injection. The E. coli infected ticks also showed down-
regulated expression of Rmcystatin-3 (Fig. 5A). The protein level
of Rmcystatin-3 knockdown in infected hemocytes was also
conﬁrmed byWestern blot analysis (Fig. 5B). At 24 h post-injection,
hemolymph was collected and spread on LB agar plates and incu-
bated overnight at 37 C. The CFU in each plate were counted and
compared. The Rmcystatin-3 silenced group presented
8.3 ± 1.8 CFU per plate whereas the non-related gene group showed
64 ± 22 CFU per plate, a reduction of approximately 78% (Fig. 5C).
4. Discussion
In this study, we describe a novel cysteine protease inhibitor
named Rmcystatin-3. The nucleotide sequence of Rmcystatin-3 is
composed of 426 bp encoding a 142 amino acids protein with
predicted signal peptide of 23 aa. The mature protein presents a
theoretical molecular weight of 13 kDa, isoelectric point of 5.39 andTable 1
Dissociation constant (Ki) of Rmcytatin-3 for different
cysteine proteinases.
Enzyme Ki (nM)
Cathepsin B 136 ± 16.70
Cathepsin L 2.48 ± 0.08
BmCl-1 1.80 ± 0.214
Papain N.I
N.I ¼ Not inhibited.highly conserved domains of the cystatin family: a glycine residue
on the N-terminal region followed by a hairpin loop composed of
QxVxG and a second hairpin formed by the pair PW. Interestingly,
Rmcystatin-3 possesses a second QxVxG motif (Fig. 1A) which may
contribute to its inhibitory speciﬁcity. Also the absence of the SND
domain [36] suggest that Rmcystatin-3 inhibitory activity against
legumain will be unfavorable.
Rmcystatin-3 transcript was present in several tick tissues e
hemocytes, fat body and salivary gland e but with dominant
presence in hemocytes (Fig. 4A and B) which are related to immune
response [37]. In ticks there are 3 subpopulations of hemocytes that
has been describe [38]: plasmatocytes, granulocytes I and gran-
ulocytes II, associated with phagocytosis of bacteria and yeast [7],
moreover in R. microplus the phagocytic activity to Saccharomyces
cerevisiae was related to the production of reactive oxygen species
[8]. To establish the role of Rmcystatin-3 within tick immunity, RNA
interference assays were performed in ticks infected with gram-
negative bacteria (E. coli). The Rmcystatin-3 gene knockdown was
evaluated by quantitative PCR (Fig. 5A) and Western blot (Fig. 5B),
revealing that Rmcystatin-3 silencing was successful although not
completely 24 h after the injection. It is important to note that the
PBS injection was enough to decrease the expression of
Rmcystatin-3 to 50% and the injection of E. coli to almost 10%,
suggesting that Rmcystatin-3 takes part in tick response to physical
Fig. 5. Rmcystatin-3 gene silencing though RNA interference. (A): Analysis of
Rmcystatin-3 mRNA in silenced and non-silenced ticks by quantitative PCR. The error
bars correspond to the standard error from the mean of two independent experiments.
(B): Protein analysis in hemocytes of silenced ticks by Western blot, (1) hemocytes
from ticks injected with dsRmcystatin-3 and (2) hemocytes from ticks injected with
dsLac (non-related control). (C): Effect of Rmcystatin-3 silencing upon gram-negative
bacterial infection. Fully engorged females were injected with E. coli suspension
(1  104 CFU/mL) and with dsRmcystatin-3 (3.5 mg/mL) or dsLac (3.5 ug/mL). 24 h post-
injection hemolymph was collected and added to LB agar plates containing kanamycin
(20 mg/mL). 48 h post-injection, number of bacteria (CFU) on each plate were obtained
and compared. The error bars correspond to the standard error from the mean of two
independent experiments.
S. Lu et al. / Biochimie 106 (2014) 17e2322stress and bacterial challenge. The silencing of Rmcystatin-3 in
infected ticks drastically reduced the number of bacteria (CFU)
survive in the hemolymph in comparison to the non-related
silenced ticks (Fig. 5C) indicating that Rmcystatin-3 may be a
negative modulator of tick immune response.
Several invertebrate cystatins have been associated with
different functions [39e42]. In ticks, cystatins were related to
parasiteehost interface. The sialostatin L, a cystatin from the sali-
vary gland of I. scapularis, displays an anti-inﬂammatory and
immunosuppressive activity on host immunity, is capable of
inhibiting lymphocyte proliferation and modulating cytokines
levels [26,27]. To date only one tick cystatin has been related to tick
immunity, Hlcys-2 from H. longicornis expressed in midgut and
hemocytes, and it was up-regulated during LPS challenge and
infectionwith B. gibsoni. In addition, the recombinant inhibitor was
able to inhibit B. gibsoni growth in vitro [21]. In contrast,
Rmcystatin-3 expression was down-regulated during bacterial
infection suggesting that this inhibitor acts as a negative modulator
of tick immune response, for example, controlling cysteine pro-
teases in the production of antimicrobial peptide, in a similar
manner described in midgut [15].Kinetics assays with recombinant Rmcystatin-3 revealed a high
afﬁnity for cathepsin L (Ki ¼ 2.5 nM). The relationship between
cathepsins and immunity is better understood in vertebrates where
cathepsins are actively involved in MHC class II antigen presenta-
tion [43,44]. A proteomic approach for hemocytes-like cell culture
of Drosophila reveal the presence of several cysteine proteases but
it's role is still unclear [45]. In the Chinese shrimp Fenneropenaeus
chinesis a cathepsin L like proteases were up-regulated during
WSSV (White Spot syndrome Virus) and bacteria (Vibrio) challenge
[46], also the transcriptome shows that several cysteine proteases
are up-regulated during infection [47]. Taking all our data together
with other studies [48e50] reinforce the role of cysteine proteases
and probable their inhibitor such as cystatin in invertebrate
immunity.
In this work, we characterize a novel type-2 cystatin inhibitor
name Rmcystatin-3 identiﬁed in hemocytes of R. microplus ticks;
together with the RNA interference, our results strongly suggest the
role of Rmcystatin-3 in tick immune response during bacterial
challenge. We hypothesized that Rmcystatin-3 act as a negative
modulator of tick immunity through inhibition of a cysteine pro-
tease in tick hemocytes, which physiologically control a proteolytic
pathway decreasing the production of immune effectors.Conﬂict of interest
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